Nanjing Immunophage Biotech Co., Ltd
Nanjing Immunophage Biotech Co., Ltd
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IPG1094 Phase I Study for China Healthy Participants | Healthy Volunteers | Recruiting | Phase 1 | 2026-08-10 | NCT07679113 | |
| IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-06-29 | NCT07508761 | |
| Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2) | Moderately to Severely Active Ulcerative Colitis (UC) | Not yet recruiting | Phase 2 | 2026-04-17 | NCT07535489 | |
| Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients | Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2025-09-24 | NCT06212076 |